Cresilon

Website

Cresilon, Inc.

95 Investors
Hemostatic Medical Devices
BROOKLYN, NY

Cresilon is a biotechnology company that develops and manufactures innovative hemostatic medical devices. Its proprietary, plant-based hydrogel technology is designed to stop bleeding in seconds, addressing applications in both veterinary and human health markets.

Products & Team

VETIGEL®

Veterinary Medical DeviceSeed

A plant-based hemostatic gel developed for the veterinary market. It is supplied in a pre-filled syringe and is designed to stop bleeding from surgical or traumatic wounds in seconds without special preparation or storage conditions.

Value Proposition

Provides veterinarians with a fast, reliable, and easy-to-use tool to control bleeding during a wide range of procedures, from dental extractions to tumor removals, improving surgical outcomes.

Pain Points

Customers in both markets need to manage uncontrolled bleeding, which can complicate procedures, extend recovery times, and increase risk to the patient. Traditional methods can be slow to act, difficult to apply in chaotic environments, or less effective on severe wounds.

Stops bleeding in secondsDerived from plant-based polymersCreates a mechanical seal without needing manual pressureBiocompatible for veterinary useSupplied in a ready-to-use, pre-filled syringe
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
BROOKLYN, NY
Primary headquarters

Funding History

Total Raised:
$17.2M
E

Security Offering

April 2025
$34.8M
Target
Progress
49%
Raised
$17.2M
Target
$34.8M
#000172805425000003